PRGN-3005
Precigen therapeutics
['ovarian', '$pgen']
precigen announces positive phase 1 data for prgn-3005 autologous ultracar-t cells manufactured overnight for infusion next day to advanced stage platinum resistant #ovarian #cancer patients $pgen #asco23 #asco2023 
No investment advice. Do your own DD Market is all about taking the shares from the weak holders& providing opportunities to those that have the stamina to hold